June 3, 2024

Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This Viewpoint explores the effects of weight loss achieved through GLP-1–based antiobesity medications on weight regain, fat-free mass, and skeletal muscle mass in people with obesity.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Conte et al. (Mon,) studied this question.

synapsesocial.com/papers/68e665f2b6db6435875f2051 https://doi.org/https://doi.org/10.1001/jama.2024.6586

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1What is the pipeline for future medications for obesity?2024 · 293 citations
2Body fat and fat-free mass inter-relationships: Forbes's theory revisited2007 · 121 citations
3The Physiological Effects of Weight-Cycling: A Review of Current Evidence2024 · 24 citations
4Weight loss diet studies: we need help not hype2016 · 57 citations
5Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism2024 · 106 citations

Preguntar a la IA

Me gusta

Guardar